🔴 GRAIL is trading 4.3% down today with no clear company-specific catalyst

GRAIL is trading 4.3% lower at $134.07 on October 1, 2026, with no new company-specific announcement clearly explaining the decline.

• The latest major catalyst was the FDA advisory panel’s favorable September 23 vote on Galleri, which fueled the preceding rally.
• Rising Treasury yields and broader rate concerns may weigh on risk appetite, though evidence does not directly link them to GRAIL’s drop. Reuters reported the 10-year Treasury yield rose to 5.34%, its highest since 2002.